Andrea Tan
Stock Analyst at Goldman Sachs
(0.97)
# 3,859
Out of 4,996 analysts
46
Total ratings
38.89%
Success rate
-12%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andrea Tan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Maintains: Buy | $114 → $142 | $137.03 | +3.63% | 11 | Aug 13, 2025 | |
| IOVA Iovance Biotherapeutics | Maintains: Buy | $16 → $8 | $2.11 | +279.15% | 7 | May 12, 2025 | |
| TARS Tarsus Pharmaceuticals | Maintains: Neutral | $46 → $51 | $56.29 | -9.40% | 4 | May 5, 2025 | |
| DAWN Day One Biopharmaceuticals | Maintains: Buy | $39 → $27 | $6.77 | +298.82% | 6 | Mar 25, 2025 | |
| SGMT Sagimet Biosciences | Maintains: Neutral | $23 → $6 | $7.34 | -18.26% | 5 | Jul 1, 2024 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Neutral | $31 | $32.80 | -5.49% | 1 | Jun 5, 2024 | |
| RLMD Relmada Therapeutics | Downgrades: Sell | $3 → $2 | $1.81 | +10.50% | 3 | Jun 5, 2024 | |
| KOD Kodiak Sciences | Reinstates: Sell | $2 | $15.80 | -87.34% | 1 | Dec 11, 2023 | |
| KRYS Krystal Biotech | Initiates: Buy | $160 | $167.82 | -4.66% | 1 | Nov 20, 2023 | |
| ABCL AbCellera Biologics | Maintains: Buy | $27 → $24 | $4.74 | +406.33% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $10 → $4 | $1.00 | +300.00% | 2 | Jan 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $178 → $375 | $424.23 | -11.60% | 1 | Dec 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $120 → $80 | $33.62 | +137.95% | 2 | May 24, 2022 |
Insmed
Aug 13, 2025
Maintains: Buy
Price Target: $114 → $142
Current: $137.03
Upside: +3.63%
Iovance Biotherapeutics
May 12, 2025
Maintains: Buy
Price Target: $16 → $8
Current: $2.11
Upside: +279.15%
Tarsus Pharmaceuticals
May 5, 2025
Maintains: Neutral
Price Target: $46 → $51
Current: $56.29
Upside: -9.40%
Day One Biopharmaceuticals
Mar 25, 2025
Maintains: Buy
Price Target: $39 → $27
Current: $6.77
Upside: +298.82%
Sagimet Biosciences
Jul 1, 2024
Maintains: Neutral
Price Target: $23 → $6
Current: $7.34
Upside: -18.26%
Arrowhead Pharmaceuticals
Jun 5, 2024
Initiates: Neutral
Price Target: $31
Current: $32.80
Upside: -5.49%
Relmada Therapeutics
Jun 5, 2024
Downgrades: Sell
Price Target: $3 → $2
Current: $1.81
Upside: +10.50%
Kodiak Sciences
Dec 11, 2023
Reinstates: Sell
Price Target: $2
Current: $15.80
Upside: -87.34%
Krystal Biotech
Nov 20, 2023
Initiates: Buy
Price Target: $160
Current: $167.82
Upside: -4.66%
AbCellera Biologics
Aug 4, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $4.74
Upside: +406.33%
Jan 9, 2023
Maintains: Sell
Price Target: $10 → $4
Current: $1.00
Upside: +300.00%
Dec 20, 2022
Maintains: Buy
Price Target: $178 → $375
Current: $424.23
Upside: -11.60%
May 24, 2022
Maintains: Neutral
Price Target: $120 → $80
Current: $33.62
Upside: +137.95%